Sano, Shiela Marie L.
HRN: 04-41-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2022
CEFTRIAXONE 1G (VIAL)
09/07/2022
09/14/2022
IV
2gm
OD
T/C Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes